本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Travere Therapeutics, Inc.

16.51
-0.1500-0.90%
盘后16.510.00000.00%16:34 EDT
成交量:136.72万
成交额:2,291.05万
市值:14.66亿
市盈率:-5.95
高:17.02
开:16.66
低:16.47
收:16.66
数据加载中...
2023/05/04

重要事件披露

8-K - Current report
2023/05/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/01

重要事件披露

Form 8-K - Current report
2023/04/12

重要事件披露

8-K - Current report
2023/03/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/01

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/03/01

重要事件披露

8-K - Current report
2023/02/23

重要事件披露

8-K - Current report
2023/02/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/17

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/10/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/27

重要事件披露

8-K - Current report
2022/10/27

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]